Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

IKOS reports excellent fund performance for May and 2010, completes NFA audit

Monday, June 14, 2010
Opalesque Industry Updates - IKOS today reported excellent fund performance in May 2010, with IKOS FX up 6.82% (+17.43% YTD), IKOS Futures up 5.83% (+10.70% YTD), and the IKOS Hedge Fund returning 3.05% (+5.26% YTD), whilst the HFRX Global Hedge Fund Index was down 2.64% and the UCITS HFS Index lost 1.08% in the month.

On 11 January 2010, the NFA, which regulates futures activities, commenced a routine desk audit of IKOS CIF Limited.

IKOS established a team comprising the Director of Finance and Compliance, George Constantinides, IKOS’ General Counsel, as well as the Financial Controller, Operations Manager, and three Accountants, to work closely with the NFA auditors during all phases of the audit.

IKOS’ commitment to upholding the NFA’s standards, and the wider adherence to best practice and regulatory compliance, was reflected and reaffirmed in the successful completion of the audit. This further reflects the governance ethos focusing on systems, processes and controls initiated by IKOS and put at the centre of the Board's agenda. The Board's focus on compliance has seen the appointment of a Risk Manager and the establishment of a Risk Management Committee, which reports directly to the Board.

The completion of the audit follows IKOS’ attainment of a SAS 70 Type I Report in March 2010, which concentrated on the completeness and effective design of the firms’ internal controls. This will be supplemented by a SAS 70 Type II Report later this year which will further test the effective operation of these controls.

In addition to complying with the standards set by the NFA, IKOS is also regulated by the CySEC in Cyprus as well as the SEC and CFTC in the US.

ABOUT IKOS
IKOS launched its first fund in 1995. With more than 75 professionals and $1.7 billion in assets under management, IKOS operates a global infrastructure from its Cyprus headquarters, utilizing execution sites, and research facilities in a number of locations including New York, Tokyo, London, and Vienna.

The firm is a specialist in global quantitative trading of all asset classes using strategies which apply the scientific method to investment management. IKOS creates state of the art proprietary technology to capture Alpha from markets which are becoming increasingly electronic. Over the years, IKOS’ investment programs have benefited investors through consistency of returns, asset protection and risk reduction.

In 2009 the IKOS FX Fund was awarded the EuroHedge Fund of the Year Award in the Managed Futures and Currency category. IKOS is now launching a UCITS III FX Fund in partnership with Deutsche Bank. The IKOS Currency Strategy has been available on the dbSelect Platform since 2006, and became available on the WR platform in 2010. Corporate website: www.ikosam.com

- FG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its